NovoCure NVCR
NASDAQ NVCR
$14.94 -0.98 (-6.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

NovoCure (NVCR) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

NovoCure's Return on Capital Employed [ROCE] was -27.05% in Q2 2026, up 7.67 percentage points from -34.72% a year earlier and up 4.65 percentage points from the prior quarter.

Analysis

NovoCure (NVCR) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at NovoCure came in at -19.24%, up 19.77 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of -23.90 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -39.01% in FY2024 (-15.48 pp), -23.53% in FY2023 (-14.64 pp), -8.89% in FY2022 (-4.24 pp) and -4.65% in FY2021 (-9.31 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -35.89% (Q4 2024) and -0.90% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for three straight quarters, with an average year-over-year change of -2.87 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2025 (a gain of 18.00 percentage points); the worst was Q2 2025 (a drop of 16.17 percentage points).
  • Per Business Quant data, NVCR's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -31.69% (Q1 2026), -17.89% (Q4 2025) and -33.50% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 8.30%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 7.98%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 6.42%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 18.58%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 8.34%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 13.69%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 10.83%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 11.99%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 6.00%
10 NovoCure 1.74 Bn -614.09 Mn 142.48 Mn -27.05%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.05%
Mar 31, 2026 -31.69%
Dec 31, 2025 -17.89%
Sep 30, 2025 -33.50%
Jun 30, 2025 -34.72%
Mar 31, 2025 -33.27%
Dec 31, 2024 -35.89%
Sep 30, 2024 -32.96%
Jun 30, 2024 -18.55%
Mar 31, 2024 -22.00%
Dec 31, 2023 -24.08%
Sep 30, 2023 -22.51%
Jun 30, 2023 -18.74%
Mar 31, 2023 -14.40%
Dec 31, 2022 -8.74%
Sep 30, 2022 -6.81%
Jun 30, 2022 -5.28%
Mar 31, 2022 -4.43%
Dec 31, 2021 -4.49%
Sep 30, 2021 -0.90%
API Access

NovoCure Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NVCR&period=max&api_key=YOUR_API_KEY